SciSparc Ltd. (NASDAQ:SPRC – Get Free Report)’s share price fell 1% during trading on Tuesday . The stock traded as low as $0.47 and last traded at $0.49. 2,290,869 shares traded hands during mid-day trading, a decline of 72% from the average session volume of 8,072,014 shares. The stock had previously closed at $0.50.
SciSparc Price Performance
The business has a 50 day moving average price of $0.50 and a two-hundred day moving average price of $0.35.
SciSparc Company Profile
SciSparc Ltd., a clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies. Its drug development programs include SCI-110 for the treatment of Tourette syndrome and Alzheimer's disease and agitation; SCI-160 for the treatment of pain; SCI-210 for the treatment of autism spectrum disorder and status epilepticus; and CannAmide, an anti-inflammatory and chronic pain solution.
See Also
- Five stocks we like better than SciSparc
- Health Care Stocks Explained: Why You Might Want to Invest
- Hims & Hers Earnings Could Be a Game Changer—What to Do Now
- With Risk Tolerance, One Size Does Not Fit All
- DeepSeek IPO Remains Far Off—Investors Eye 4 Chinese AI Stocks
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Mortgage Market Bottom? Why Rocket Companies Could Be a Buy
Receive News & Ratings for SciSparc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SciSparc and related companies with MarketBeat.com's FREE daily email newsletter.
